Xeris Biopharma Holdings Overview

Xeris Biopharma Holdings Profit Margin

Profitability ratio analysis for XERS.

Quarterly Profit Margin

2.69%

↑ 117.52% YoY

As of Mar 2026

Annual Profit Margin (TTM)

3.81%

↑ 118.71% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin